Full video transcriptClick to expand
Auto-generated transcript of @rateyourcollections's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00What actually happens if you take MK-677 for 90 days?
- 0:04This gets weird.
- 0:05Day one, nothing crazy.
- 0:08You take it, you wait, but your body's already reacting.
- 0:12By week one, you're starving.
- 0:14Like eating everything in sight, your appetite goes insane.
- 0:18Month one, sleep hits different.
- 0:20Deep heavy, almost too good.
- 0:22You wake up feeling unreal.
- 0:24Month two, now people notice, strength's climbing.
- 0:28You look fuller, but so does your face sometimes.
- 0:32Yeah, water retention can creep in.
MK-677 for 90 days: what the research actually shows
Quick answer
MK-677 is an orally active ghrelin receptor agonist that elevates growth hormone and IGF-1 through pituitary stimulation rather than direct GH administration. The appetite, sleep architecture, and fluid retention effects described in the video are consistent with known pharmacodynamic effects documented in clinical trials, primarily conducted in elderly or GH-deficient populations. Prolonged use has been associated with fasting hyperinsulinemia and edema, effects the video does not fully address.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For MK-677 for 90 days: what the research actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
MK-677 for 90 days: what the research actually shows is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "MK-677 for 90 days: what the research actually shows" from .. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: MK-677 is an orally active ghrelin receptor agonist that elevates growth hormone and IGF-1 through pituitary stimulation rather than direct GH administration.
The reason this review is not generic is the source wording and the canonical claim label "peptides what happens if you take mk 677 for 90 days mk677 gym gymbro." In this clip, the useful excerpt is: "What actually happens if you take MK-677 for 90 days?" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
MK-677 is an orally active ghrelin receptor agonist that elevates growth hormone and IGF-1 through pituitary stimulation rather than direct GH administration.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- MK-677 is an orally active ghrelin receptor agonist that elevates growth hormone and IGF-1 through pituitary stimulation rather than direct GH administration. The appetite, sleep architecture, and fluid retention effects described in the video are consistent with known pharmacodynamic effects documented in clinical trials, primarily conducted in elderly or GH-deficient populations. Prolonged use has been associated with fasting hyperinsulinemia and edema, effects the video does not fully address.
- MK-677 is not FDA-approved for any use and remains an investigational compound with limited long-term human safety data.
- The appetite increase is pharmacologically real: ghrelin receptor agonism drives hunger signals, documented in Murphy et al. (1998) within the first week of use.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- MK-677 is not FDA-approved for any use and remains an investigational compound with limited long-term human safety data.
- The appetite increase is pharmacologically real: ghrelin receptor agonism drives hunger signals, documented in Murphy et al. (1998) within the first week of use.
- Sleep architecture changes, including increased slow-wave sleep, have been confirmed in clinical studies (Copinschi et al., 1997), but individual response varies significantly.
- Early body composition changes at the 60-90 day mark are substantially driven by fluid and glycogen retention, not solely lean muscle accrual.
- Multiple studies, including Svensson et al. (2000), have documented decreased insulin sensitivity with MK-677 use, a risk factor absent from this video entirely.
- Edema, including facial puffiness, is a consistent and well-documented adverse effect per Nass et al. (2008), not just an occasional cosmetic nuisance.
- Most MK-677 clinical trials were conducted in elderly or GH-deficient populations, making it difficult to generalize findings to healthy young adults using it for performance.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @rateyourcollections actually say?
The creator laid out a week-by-week progression of MK-677 effects over 90 days. They said day one produces no immediate effects, but by week one "your appetite goes insane." By month one, sleep becomes "deep, heavy, almost too good." Month two brings visible strength and fullness gains, with the caveat that "water retention can creep in" and even the face can look puffier. This is a reasonably honest framing, notably more cautious than most gym-bro peptide content. They're not promising you'll look like a bodybuilder. They're describing a progression with some downsides included. That said, calling it "weird" and leaving out the more serious physiological concerns is doing a lot of work to keep this video feel-good.
Does the science back this up?
Mostly, yes, but with important caveats. MK-677 (ibutamoren) is a ghrelin receptor agonist that stimulates growth hormone and IGF-1 secretion. The appetite surge is real and well-documented. A randomized trial by Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism) confirmed significant increases in hunger scores with MK-677 administration, tied directly to ghrelin pathway activation. The sleep effects the creator describes have some backing too. Copinschi et al. (1997, Sleep) found MK-677 increased REM sleep duration and slow-wave sleep in healthy older adults, which aligns with the "deep, heavy" sleep description. The strength and body composition changes over 60-90 days are plausible given sustained IGF-1 elevation, though studies in healthy young adults are sparse. Most research has been done in elderly populations or patients with growth hormone deficiency, which limits how far you can extrapolate.
What did they get wrong (or right)?
They got the appetite and sleep effects roughly right. Credit where it's due. But the framing of month two as people noticing gains and strength "climbing" skips over some important nuance. A lot of early body composition changes with MK-677 are tied to water and glycogen retention, not contractile muscle tissue. Presenting a fuller look as gains without separating lean mass from fluid is a meaningful omission. The water retention mention is good, but calling it something that "can creep in" undersells it. Nass et al. (2008, Annals of Internal Medicine) documented edema as one of the more consistent adverse effects in longer MK-677 trials. The face puffiness the creator mentions isn't just cosmetic vanity. It's a sign of systemic fluid shifts. Also absent from this video: any mention of fasting insulin elevation, which multiple studies have flagged as a concern with prolonged use.
What should you actually know?
MK-677 is not approved by the FDA for any indication. It is not a SARM, despite being marketed alongside them. It is an investigational compound. That means clinical data is limited, long-term human safety data is thin, and quality control on the products sold online varies dramatically. The ghrelin agonism that drives the appetite and sleep effects also has downstream consequences worth knowing. Chronic ghrelin stimulation has implications for insulin sensitivity. A study by Svensson et al. (2000, Journal of Clinical Endocrinology and Metabolism) noted decreased insulin sensitivity in subjects on MK-677. Anyone with prediabetes, metabolic syndrome, or a family history of type 2 diabetes should treat this with serious caution. The "unreal" sleep and the "starving" appetite the creator describes are real pharmacological effects, but they are not signs the compound is simply optimizing your biology. They are signs of active hormonal manipulation with systemic effects that extend well beyond the gym.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
. · TikTok creator
3.1K views on this video
What happens if you take mk -677 for 90 days… #mk677 #gym #gymbro #xyzabc #fyp
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about mk-677?
MK-677 is not FDA-approved for any use and remains an investigational compound with limited long-term human safety data.
What does the video say about the appetite increase?
The appetite increase is pharmacologically real: ghrelin receptor agonism drives hunger signals, documented in Murphy et al. (1998) within the first week of use.
What does the video say about sleep architecture changes, including increased slow-wave sleep, have been confirmed?
Sleep architecture changes, including increased slow-wave sleep, have been confirmed in clinical studies (Copinschi et al., 1997), but individual response varies significantly.
What does the video say about early body composition changes at the 60-90 day mark?
Early body composition changes at the 60-90 day mark are substantially driven by fluid and glycogen retention, not solely lean muscle accrual.
What does the video say about multiple studies, including svensson et al. (2000), have documented decreased?
Multiple studies, including Svensson et al. (2000), have documented decreased insulin sensitivity with MK-677 use, a risk factor absent from this video entirely.
What does the video say about edema, including facial puffiness,?
Edema, including facial puffiness, is a consistent and well-documented adverse effect per Nass et al. (2008), not just an occasional cosmetic nuisance.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by ., not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.